Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
pediatric 6 year old got an adult Hep A vaccine (Havrix); pediatric 6 year old got an adult Hep A vaccine (Havrix); This non-serious case was reported by a other health professional and described the occurrence of adult product administered to child in a 6-year-old female patient who received HAV (Havrix adult) for prophylaxis. On 29-OCT-2025, the patient received the 1st dose of Havrix adult. On 29-OCT-2025, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: pediatric 6 year old got an adult Hep A vaccine (Havrix)) and overdose (Verbatim: pediatric 6 year old got an adult Hep A vaccine (Havrix)). The outcome of the adult product administered to child and overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-OCT-2025 Clinical coordinator called in to reported that a pediatric 6 year old got an adult Hep A vaccine (Havrix) . Physician thinks it was fine.